Director Dennies Varughese, Pharm.D. was quoted in the article “How Counsel Balance USPTO and Court Edicts on Section 101,” published by Managing IP.

He comments on navigating the gap between USPTO guidance and federal court interpretation of Section 101 criteria. He said, “Looking at it from the court’s perspective, why should a court give deference to the USPTO’s guidance when it is well within its prerogative to disregard that?”